This note at the bottom of the order leads me to believe that Bioject did respond:
The latest 8-K uses the same address of the Tigard, OR hq, so I assume that the SEC at least now has a current address.
So, I guess we are in trading suspension limbo until next month.
According to the bio on the BJCT website http://www.bioject.com/about/bios#chow , CEO Chow supposedly has some expertise in SEC filing. So, why did he let this happen?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.